z-logo
Premium
Effects of almitrine on the release of catecholamines from the rabbit carotid body in vitro
Author(s) -
Almaraz L.,
Rigual R.,
Obeso A.,
Evrard Y.,
Gonzalez C.
Publication year - 1992
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/j.1476-5381.1992.tb14397.x
Subject(s) - chemoreceptor , carotid body , endocrinology , dopamine , medicine , mechanism of action , chemistry , veratridine , in vitro , biology , pharmacology , biochemistry , stimulation , sodium , receptor , organic chemistry , sodium channel
1 . Almitrine increases ventilation by stimulating the carotid body (CB) arterial chemoreceptors but neither its intraglomic target nor its mechanism of action have been elucidated. 2 . We have tested the hypothesis that chemoreceptor cells are targets for almitrine by studying its effects on the release of 3 H‐catecholamines in an in vitro rabbit CB preparation. 3 . It was found that almitrine (0.3 and 1.5 × 10 −6 m ; i.e. 0.2 and 1 mg l −1 ) increases the resting release of 3 H‐catecholamines from CBs (previously loaded with [ 3 H]‐tyrosine) incubated in a balanced 95% O 2 /5% CO 2 ‐equilibrated solution. 4 . Almitrine at a concentration of 3×10 −6 m (2mg l −1 ) also augmented the release of 3 H‐catecholamines elicited by incubating the CBs in a hypoxic solution (equilibrated with 7% O 2 /5% CO 2 in N 2 ), by high external K + (35 m m ) and by veratridine (2 × 10 −5 m ), but did not modify release induced by dinitrophenol (7.5 × 10 −5 m ). 5 . At the same concentration (3 × 10 −6 m ), almitrine increased the rate of dopamine synthesis and was ineffective in modifying the cyclic AMP levels in either normoxic or hypoxic CBs. 6 . It is concluded that chemoreceptor cells are the intraglomic targets for almitrine. The mechanisms of action of almitrine on chemoreceptor cells are discussed.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here